1. At a Glance
Transpek Industry Ltd (TIL), part of the Excel Group, is that uncle who claims to be a “global supplier” but still insists on spelling WhatsApp as “Watsapp.” Market cap: ₹746 Cr. CMP: ₹1,335 — exactly the same as its book value (PBV = 1.0). A value investor’s wet dream? Wait, not so fast.
3-month return: –21.7% (ouch). One-year return: –19.9% (double ouch). Five-year return: –8.6% (somebody call SEBI, this stock is stuck in reverse gear). Yet the company flaunts EPS ₹98.5, ROE 7.8%, and pays a 200% dividend. Translation: “Bhai, hum growth nahi dete, but cash bhejte hain.”
Debt? A comfortable ₹94 Cr with D/E 0.13. Promoters own 57.5% and haven’t budged an inch in years. Operational margin ~16%. Export-driven (88%). Customers? Six of them contribute 78% of revenue. One sneeze in North America, and TIL catches pneumonia in Vadodara.
2. Introduction
If you ask any Vadodara chemist about Transpek, they’ll say, “Arre haan, yeh woh chlorine-wale log.” Indeed, TIL has been making chlorinated products since Indira Gandhi’s first term. From Thionyl Chloride to fancy acid chlorides with names that sound like failed IIT JEE questions, they churn chemicals for pharma, agro, dyes, and polymers.
The company is like that old Gujarati joint family house: heritage walls (since 1965), strong foundations (Excel Group), lots of members abroad (88% exports), but growth has been slow — like waiting for a dosa in a crowded wedding.
Between FY20–FY24, sales actually shrunk from ₹827 Cr to ₹580 Cr before recovering to ₹652 Cr. PAT too fell from ₹83 Cr to ₹39 Cr before inching up to ₹55 Cr in FY25. It’s like they pressed Ctrl+Z on growth for five years, and only recently found the redo button.
Question for you: would you trust a company that took 5 years to realise “stagnation ≠ strategy”?
3. Business Model – WTF Do
